FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Pharmaceutical | Therapeutics
Diverse genome sequences provided a powerful tool for studying risk of heart disease
On Dec. 8, 2021, in a large-scale study of people from diverse ancestries, researchers narrowed down the number…
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
FDA approved new drug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
Scientists found genetic link to clogged arteries
On Mar. 24, 2021, scientists from Washington University School of Medicine in St. Louis announced they had identified…
SARS-CoV-2 needs cholesterol to invade cells and form mega cells
On Jan. 25, 2021, HHMI investigators reported that cholesterol, the waxy compound better known for clogging arteries, helps…
The FDA approved non-statin drug to treat high cholesterol
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
Texas Biomed geneticists announced discovery that a particular gene, VNN1, plays a major role in the regulation of HDL cholesterol levels
In 2007, Texas Biomed geneticists announced their discovery that a particular gene, VNN1, plays a major role in…
Michael Stuart Brown was awarded Nobel Prize in Medicine
In 1985, Michael Stuart Brown from the University of Texas Southwestern Medical Center at Dallas was awarded the…
Stanford Medicine researchers discovered link between exercise and increased ‘good’ (HDL) cholesterol levels
In 1975, Stanford Medicine researchers discovered link between exercise and increased ‘good’ (HDL) cholesterol levels. The Coronary Primary…
Stanford Medicine hosted the first multicenter trial to demonstrate that lowering cholesterol levels prevents heart disease
In 1971, Stanford Medicine hosted the first multicenter trial to demonstrate that lowering cholesterol levels prevents heart disease.